Aptose Biosciences Inc.
NASDAQ:APTO
0.4 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.124 | 0.169 | 0.043 | 0.1 | 0.024 | 0.005 | 0.447 | 0.048 | 0 | 0.001 | 0.001 | 0.068 | 0.069 | 0.073 |
| Cost of Revenue
| 0.475 | 0.507 | 0.617 | 0.646 | 0.627 | 0.084 | 0.089 | 0.115 | 0.069 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.002 | 0.015 | 0.003 | 0.001 | 0.021 | 0.04 | 0 | -1.171 | -0.946 | -0.203 | -0.069 | 0 |
| Gross Profit
| -0.475 | -0.507 | -0.617 | -0.646 | -0.627 | -0.084 | -0.089 | -0.115 | -0.069 | 0 | 0 | 0 | 0 | 0 | 0.124 | 0.169 | 0.041 | 0.085 | 0.021 | 0.004 | 0.426 | 0.008 | 0 | 1.172 | 0.946 | 0.271 | 0.137 | 0.073 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0.953 | 0.85 | 0.875 | 0.8 | 0.953 | 0.167 | 0 | 1,171.631 | 1,418 | 4 | 2 | 1 |
| Reseach & Development Expenses
| 37.4 | 28.088 | 45.985 | 29.288 | 16.835 | 18.733 | 6.274 | 7.679 | 4.507 | 0.004 | 2.779 | 3.218 | 1.932 | 2.352 | 2.386 | 3.447 | 6.122 | 3.164 | 9.297 | 11.47 | 19.661 | 9.144 | 5.666 | 6.372 | 2.832 | 2.17 | 1.922 | 2.104 |
| General & Administrative Expenses
| 15.591 | 14.433 | 19.324 | 26.345 | 9.9 | 10.321 | 5.502 | 6.128 | 7.046 | 0.008 | 6.071 | 2.2 | 2.489 | 2.689 | 2.976 | 3.123 | 3.888 | 3.848 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -0.149 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.745 | 0.22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 15.442 | 14.433 | 19.324 | 26.345 | 9.9 | 10.321 | 5.502 | 6.128 | 7.046 | 0.008 | 6.071 | 2.2 | 2.489 | 2.689 | 2.976 | 3.123 | 4.633 | 4.068 | 5.031 | 5.438 | 3.608 | 3.125 | 3.185 | 4.172 | 2.437 | 1.153 | 1.304 | 1.088 |
| Other Expenses
| 33.273 | 0.081 | 0.138 | 0.135 | 0.122 | 0.053 | 0.05 | 0.08 | 0.048 | 0 | 0.005 | 0.005 | 0.217 | 0.057 | 0.082 | 0.173 | 0.319 | 0.479 | 0.779 | 0 | 0.308 | 0 | 1.28 | 2.408 | 1.777 | 0.203 | 0.275 | 0.363 |
| Operating Expenses
| 52.842 | 42.602 | 65.447 | 55.768 | 26.857 | 29.107 | 11.826 | 13.887 | 11.601 | 0.012 | 8.855 | 5.423 | 4.464 | 5.099 | 5.443 | 6.743 | 11.075 | 7.711 | 15.107 | -17.354 | 23.576 | -13.001 | 10.131 | 12.952 | 7.046 | 3.527 | 3.501 | 3.555 |
| Operating Income
| -53.316 | -42.593 | -65.446 | -55.776 | -26.863 | -29.107 | -11.826 | -13.887 | -11.601 | -0.012 | -8.855 | -5.423 | -4.464 | -5.099 | -5.319 | -6.574 | -11.034 | -7.626 | -15.086 | 17.358 | -23.15 | 13.009 | -10.131 | -11.78 | -6.1 | -3.255 | -3.364 | -3.555 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -42.84 | -38.946 | -256.464 | -76.24 | -628.6 | 3,472.255 | -51.826 | 272.024 | 0 | -11,776.287 | -9,140 | -48 | -49 | -49 |
| Total Other Income Expenses Net
| 1.17 | 0.77 | 0.092 | 0.538 | 0.586 | -0.044 | 0.097 | -0.049 | 0.886 | 0 | -0.702 | -5.399 | -0.014 | -0.058 | 10.403 | -1.153 | 5.153 | -0.874 | -0.717 | -0.34 | 0.909 | -25.128 | 1.306 | 1.885 | 0.361 | 0.068 | 0.137 | 0.073 |
| Income Before Tax
| -52.146 | -41.823 | -65.354 | -55.238 | -26.277 | -28.868 | -11.661 | -13.858 | -10.54 | -0.012 | -9.726 | -5.399 | -4.478 | -5.157 | 5.053 | -8.128 | -6.37 | -9.012 | -16.265 | -17.582 | -22.241 | -12.119 | -8.825 | -9.895 | -5.739 | -3.12 | -3.227 | -3.483 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.695 | -48.152 | -148.069 | -90.1 | -677.726 | -3,517.053 | -49.79 | -253.42 | 0 | -9,891.882 | -8,599 | -46 | -47 | -48 |
| Income Tax Expense
| -0 | -0.77 | -0.093 | -0.53 | -0.58 | -0.044 | 0.097 | -0.035 | 0.031 | 0 | 0.239 | -5.394 | 4.478 | 5.157 | -5.053 | 8.128 | 6.37 | 9.012 | 16.265 | 17.582 | 22.241 | 12.119 | 8.825 | 9.895 | 5.739 | 3.12 | 3.227 | 3.483 |
| Net Income
| -52.146 | -41.053 | -65.261 | -54.708 | -25.697 | -28.868 | -11.661 | -13.858 | -10.54 | -0.012 | -9.726 | -5.399 | -4.478 | -5.157 | 5.053 | -8.128 | -6.37 | -9.012 | -16.265 | -17.582 | -22.241 | -12.119 | -8.825 | -9.895 | -5.739 | -3.12 | -3.227 | -3.483 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40.695 | -48.152 | -148.069 | -90.1 | -677.726 | -3,517.053 | -49.79 | -253.42 | 0 | -9,891.882 | -8,599 | -46 | -47 | -48 |
| EPS
| -7.72 | -6.67 | -10.99 | -10.03 | -7.68 | -12.97 | -7.84 | -16.32 | -13.29 | -0.015 | -12.58 | -23 | -38.27 | -92.1 | 97.24 | -177.65 | -159.94 | -237.56 | -506.19 | -551.63 | -699.79 | -452.63 | -332.17 | -379.57 | -719.71 | -445.04 | -481.96 | -626.97 |
| EPS Diluted
| -7.72 | -6.67 | -10.99 | -10.03 | -7.68 | -12.97 | -7.84 | -16.31 | -13.28 | -0.015 | -12.57 | -23 | -38.15 | -91.64 | 97.24 | -177.65 | -159.94 | -237.56 | -506.19 | -551.63 | -699.79 | -452.63 | -332.17 | -379.57 | -719.71 | -445.04 | -481.96 | -626.97 |
| EBITDA
| -52.842 | -42.065 | -64.824 | -55.162 | -26.25 | -28.976 | -11.611 | -13.73 | -11.347 | -0.012 | -8.765 | -5.357 | -4.421 | -5.042 | -15.64 | -5.248 | -15.867 | -5.66 | -12.163 | 19.565 | -21.56 | 14.49 | -7.708 | -9.372 | -4.323 | -2.984 | -3.089 | -3.12 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -125.97 | -31.087 | -368.812 | -56.59 | -506.805 | 3,913.837 | -48.266 | 303.004 | 0 | -9,369.046 | -6,478 | -44 | -45 | -43 |